Dana-Farber Launches New Oncology Decision Support Platform for Clinicians

Dana-Farber Cancer Institute has launched Solavia Decision Suite, a next-generation oncology decision support platform co-developed with NYU Langone Health. This platform integrates Dana-Farber's clinical expertise and evidence-based treatment pathways directly into oncologists' workflows, aiming to extend specialized cancer treatment guidance to patients beyond the Institute and help clinicians navigate complex treatment decisions.